The Asian Scientist 100
Tan Eng King
Institution
National Neuroscience Institute
Country
Singapore
Field
Life Sciences
Tan Eng King received the 2018 President’s Science Award for identifying clinical biomarkers, developing novel models and transforming patient care in Parkinson’s Disease. (Photo: National Neuroscience Institute)
Related articles
Bad Chemistry At Work? The Organizational Ombudsman Can Help You
If you have a work-related conflict, an ombudsman may be a better solution than constant prayer, weeping sorrowfully, or burying your head in the ground like an ostrich.
2011 Asian University Rankings: HKUST Leads The Pack
The HKUST has topped the 2011 Asian university rankings by Quacquarelli Symonds, followed by the University of Hong Kong and the National University of Singapore.
Turtle Embryos Move Within Their Eggs To Find The Warmest Side
Scientists have shown that turtle embryos not only move, they even snuggle up to the warmest side of their eggs.
Sanofi And DNDi To Tackle Nine Neglected Tropical Diseases
Sanofi and the Drugs for Neglected Diseases initiative will develop new treatments for nine neglected tropical diseases listed by the World Health Organization.
22-Year-Old Student From Monash University Finds Universe’s Missing Mass
A Monash student has made a breakthrough in the field of astrophysics, discovering what has until now been described as the Universe's 'missing mass.'
Adding Aluminium Nanoparticles To Make Super Biofuels
How to put more bang in your biofuels? Nanoparticles! A new study shows that the addition of alumina nanoparticles can improve the performance and combustion of biodiesel.
Chinese Officials And MIT Ink Collaborative Deal
Chinese officials visited MIT to encourage collaboration between MIT and Shanghai Jiao Tong University, and to establish a fellowship program that sponsors students to study at MIT.
Heart Disease, Stroke, Cancer and Diabetes Rising In Developing World
In 2008, 36.1 million people died from heart disease, stroke, chronic lung disease, cancer and diabetes, with 80 percent of cases occuring in low- and middle-income countries.
Novartis Expands Stake In Chinese Vaccine Market
Novartis announced today that it has acquired an 85 percent stake in the Chinese vaccines company Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd.